Envista Holdings Corp
NVST29.100USD
+4.390+17.77%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
4.80BMarktkapitalisierung
104.02KGV TTM
mehr Informationen über Envista Holdings Corp Unternehmen
Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Envista Holdings Corp Informationen
BörsenkürzelNVST
Name des UnternehmensEnvista Holdings Corp
IPO-datumSep 18, 2019
CEOKeel (Paul A)
Anzahl der mitarbeiter12300
WertpapierartOrdinary Share
GeschäftsjahresendeSep 18
Addresse200 S. Kraemer Blvd., Bldg. E
StadtBREA
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl92821
Telefon17148175418
Websitehttps://envistaco.com/en
BörsenkürzelNVST
IPO-datumSep 18, 2019
CEOKeel (Paul A)
Führungskräfte von Envista Holdings Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
54.94K
-804.00%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+10450.00%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+10450.00%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
50.32K
-5422.00%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
44.68K
+10450.00%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
43.62K
+10450.00%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
41.98K
-1771.00%
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
33.32K
-54097.00%
Mr. Mischa M. Reis
Mr. Mischa M. Reis
Senior Vice President - Strategy and Corporate Development
Senior Vice President - Strategy and Corporate Development
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
54.94K
-804.00%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+10450.00%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+10450.00%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
50.32K
-5422.00%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
44.68K
+10450.00%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
43.62K
+10450.00%
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
Northern America
348.10M
51.96%
Emerging markets
152.00M
22.69%
Western Europe
139.10M
20.76%
Other developed markets
30.70M
4.58%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
9.76%
BlackRock Institutional Trust Company, N.A.
8.71%
Ariel Investments, LLC
7.30%
Dimensional Fund Advisors, L.P.
5.80%
Atlanta Capital Management Company, L.L.C.
5.27%
Andere
63.17%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
9.76%
BlackRock Institutional Trust Company, N.A.
8.71%
Ariel Investments, LLC
7.30%
Dimensional Fund Advisors, L.P.
5.80%
Atlanta Capital Management Company, L.L.C.
5.27%
Andere
63.17%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
52.98%
Investment Advisor/Hedge Fund
47.40%
Hedge Fund
10.47%
Research Firm
1.56%
Pension Fund
1.39%
Sovereign Wealth Fund
1.38%
Bank and Trust
0.53%
Individual Investor
0.52%
Private Equity
0.41%
Institutionelle Beteiligung
Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
695
191.29M
116.34%
-29.84M
2025Q3
713
196.49M
119.50%
-31.47M
2025Q2
735
199.63M
120.11%
-32.52M
2025Q1
767
200.87M
118.49%
-32.33M
2024Q4
774
200.73M
116.58%
-32.33M
2024Q3
769
198.37M
115.33%
-28.47M
2024Q2
775
193.95M
112.83%
-33.23M
2024Q1
793
187.23M
108.93%
-31.14M
2023Q4
800
189.02M
110.25%
-16.86M
2023Q3
779
181.32M
105.90%
-24.06M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
16.33M
9.93%
-591.98K
-3.50%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
14.32M
8.71%
-376.73K
-2.56%
Sep 30, 2025
Ariel Investments, LLC
12.00M
7.3%
-351.46K
-2.84%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
9.54M
5.8%
+367.36K
+4.01%
Sep 30, 2025
Atlanta Capital Management Company, L.L.C.
8.67M
5.27%
-2.15M
-19.86%
Sep 30, 2025
Franklin Mutual Advisers, LLC
8.69M
5.29%
-262.48K
-2.93%
Sep 30, 2025
Harris Associates L.P.
6.85M
4.17%
-962.59K
-12.32%
Sep 30, 2025
Gates Capital Management, Inc.
6.22M
3.78%
-105.21K
-1.66%
Sep 30, 2025
AllianceBernstein L.P.
6.10M
3.71%
+235.00
+0.00%
Sep 30, 2025
Victory Capital Management Inc.
5.91M
3.59%
+160.19K
+2.79%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Tue, Dec 2
Aktualisiert: Tue, Dec 2
Name
Anteil
State Street SPDR S&P Health Care Equipment ETF
1.75%
Schwab Ariel Opportunities ETF
1.51%
Pacer US Export Leaders ETF
0.88%
Distillate Small/Mid Cash Flow ETF
0.58%
Royce Quant Small-Cap Quality Value ETF
0.5%
Harbor Long-Short Equity ETF
0.45%
First Trust Health Care Alphadex Fund
0.41%
iShares U.S. Medical Devices ETF
0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
0.3%
DFA Dimensional US Small Cap Value ETF
0.27%
Mehr Anzeigen
State Street SPDR S&P Health Care Equipment ETF
Anteil1.75%
Schwab Ariel Opportunities ETF
Anteil1.51%
Pacer US Export Leaders ETF
Anteil0.88%
Distillate Small/Mid Cash Flow ETF
Anteil0.58%
Royce Quant Small-Cap Quality Value ETF
Anteil0.5%
Harbor Long-Short Equity ETF
Anteil0.45%
First Trust Health Care Alphadex Fund
Anteil0.41%
iShares U.S. Medical Devices ETF
Anteil0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
Anteil0.3%
DFA Dimensional US Small Cap Value ETF
Anteil0.27%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
